Serum lipoprotein(a) and reclassification of coronary heart disease risk; application of prediction in a cross-sectional analysis of an ongoing Iranian cohort
Abstract Introduction Recent studies have introduced elevated lipoprotein(a) (Lp(a)) as a risk factor for coronary heart disease (CHD). This study investigated whether the addition of Lp(a) as a novel biomarker to the Framingham Risk Score (FRS) model improves CHD risk prediction. Methods The study...
Saved in:
Main Authors: | Mojgan Ghavami (Author), Alireza Abdshah (Author), Sadaf Esteghamati (Author), Nima Hafezi-Nejad (Author), Manouchehr Nakhjavani (Author), Alireza Esteghamati (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Waist-To-Height Ratio Is a More Accurate Tool for Predicting Hypertension Than Waist-To-Hip Circumference and BMI in Patients With Type 2 Diabetes: A Prospective Study
by: Fatemeh Moosaie, et al.
Published: (2021) -
Reclassification of English Learners
by: James B. Grissom
Published: (2004) -
Neutrophil Gelatinase-Associated Lipocalin and Retinol-Binding Protein-4 as Biomarkers for Diabetic Kidney Disease
by: Fatemeh Abbasi, et al.
Published: (2020) -
Cost-effectiveness of Empagliflozin Compared to Liraglutide in Iran Based on Cardiovascular Outcome Trials in Type 2 Diabetes Mellitus
by: Nayyereh Ayati, et al.
Published: (2022) -
Therapeutic effects of resveratrol and Omega-3 in mice atherosclerosis: focus on histopathological changes
by: Shamsi Sadat Mosavi, et al.
Published: (2023)